Pharmaids Pharmaceuticals Ltd

Legal & Regulatory

Pharmaids Pharmaceuticals Legal & Regulatory

Pharmaids Pharmaceuticals filed legal complaints against Anugraha Chemicals for dishonoured cheques totalling ₹2.63 Crore in outstanding dues from a disinvestment agreement.

Value

₹2.63 Cr

Annual General Meeting

Pharmaids Pharmaceuticals Annual General Meeting

Pharmaids Pharmaceuticals held its 37th AGM via video conference on 11 Sept 2026. Four resolutions including adoption of FY26 financials and related-party-transaction approvals were tabled.

Promoter Buying (Off-Market)

Pharmaids Pharmaceuticals Promoter Buying (Off-Market)

KMP Prasanna Subramanya Bhat acquired 17,291 shares of Pharmaids Pharmaceuticals Ltd via a gift from an immediate relative. This off-market transfer is an insider disclosure.

Promoter stake change

+0.04%

Financial Results

Pharmaids Pharmaceuticals Q1 FY27 Results: Net Profit ₹1.9 Cr, Down 64.2% YoY

Pharmaids Pharmaceuticals Ltd reported revenue from operations of ₹4.1 Cr (-38.8% YoY) and net profit of ₹1.9 Cr (-64.2% YoY) for Q1 FY27.

Key figure

Net profit ₹1.9 Cr · -64.2% YoY

Financial Results

Pharmaids Pharmaceuticals Q4 FY26 Results: Net Loss of ₹1.1 Cr, Loss Narrows

Pharmaids Pharmaceuticals Ltd reported revenue from operations of ₹7.2 Cr (+50.0% YoY) and a net loss of ₹1.1 Cr for Q4 FY26.

Key figure

Net loss ₹1.1 Cr